Cargando…

Anderson-Fabry’s Disease: A Rare but Treatable Case of Fever of Unknown Origin

Anderson-Fabry’s disease (AFD) is a rare, X-linked lysosomal storage disorder caused by the complete deficiency or attenuated activity of the enzyme α-galactosidase A, leading to progressive systemic intracellular accumulation of glycosphingolipids and subsequent cellular dysfunction, inflammation a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Graziani, Francesca, Ruggio, Aureliano, Iaconelli, Antonio, Verrecchia, Elena, Morrone, Amelia, Antuzzi, Daniela, Crea, Filippo, Manna, Raffaele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SMC Media Srl 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346910/ https://www.ncbi.nlm.nih.gov/pubmed/30755957 http://dx.doi.org/10.12890/2017_000645

Ejemplares similares

Evidence of evolution towards left midventricular obstruction in severe Anderson–Fabry cardiomyopathy
por: Graziani, Francesca, et al.
Publicado: (2020)

Prognostic significance of right ventricular hypertrophy and systolic function in Anderson–Fabry disease
por: Graziani, Francesca, et al.
Publicado: (2020)

The Use of Chitotriosidase as a Marker of Active Sarcoidosis and in the Diagnosis of Fever of Unknown Origin (FUO)
por: Di Francesco, Angela Maria, et al.
Publicado: (2021)

Treatable Subsets in Cancer of Unknown Primary Origin
por: Sumi, Hajime, et al.
Publicado: (2001)

Recurrent fever of unknown origin: An overlooked symptom of Fabry disease
por: Luo, Yi, et al.
Publicado: (2020)

Biomarkers in Anderson–Fabry Disease
por: Simonetta, Irene, et al.
Publicado: (2020)

Cardiac abnormalities in Anderson-Fabry disease and Fabry’s cardiomyopathy
por: Morrissey, Ryan P, et al.
Publicado: (2011)

The distribution of hypertrophy in anderson fabry disease
por: Sado, Daniel M, et al.
Publicado: (2011)

Anderson-Fabry disease in heart failure
por: Akhtar, M. M., et al.
Publicado: (2018)

Advanced CMR Techniques in Anderson-Fabry Disease: State of the Art
por: Ponsiglione, Andrea, et al.
Publicado: (2023)

Clinical prodromes of neurodegeneration in Anderson-Fabry disease
por: Löhle, Matthias, et al.
Publicado: (2015)

Role of cardiac imaging in Anderson-Fabry cardiomyopathy
por: Serra, Walter, et al.
Publicado: (2019)

Pathologic substrate of gastropathy in Anderson-Fabry disease
por: Di Toro, Alessandro, et al.
Publicado: (2020)

Agalsidase alfa (Replagal(™)) in the treatment of Anderson-Fabry disease
por: Pastores, Gregory M
Publicado: (2007)

Time of Anderson-Fabry Disease Detection and Cardiovascular Presentation
por: Selthofer-Relatic, K.
Publicado: (2018)

Survey about the Quality of Life of Italian Patients with Fabry Disease
por: Polistena, Barbara, et al.
Publicado: (2021)

CMR demonstration of multiple morphological phenotypes in Anderson-Fabry disease
por: Deva, Djeven P, et al.
Publicado: (2015)

Gastrointestinal Involvement in Anderson-Fabry Disease: A Narrative Review
por: Caputo, Fabio, et al.
Publicado: (2021)

Cardiac Imaging in Anderson-Fabry Disease: Past, Present and Future
por: Esposito, Roberta, et al.
Publicado: (2021)

Anderson–Fabry Disease: From Endothelial Dysfunction to Emerging Therapies
por: Stamerra, Cosimo A., et al.
Publicado: (2021)

Comparative analysis of right ventricular strain in Fabry cardiomyopathy and sarcomeric hypertrophic cardiomyopathy
por: Meucci, Maria Chiara, et al.
Publicado: (2022)

Angiokeratoma Corporis Diffusum: An Uncommon Case with Suspected Anderson Fabry Disease
por: Vadher, Priyanka, et al.
Publicado: (2020)

Anderson-fabry disease: role of traditional and new cardiac MRI techniques
por: Caredda, Gloria, et al.
Publicado: (2021)

Screening for Fabry disease in unknown origin axonal polyneuropathy: to do or not to do, this is the question!
por: Rota, Eugenia, et al.
Publicado: (2020)

Circulating miR-184 is a potential predictive biomarker of cardiac damage in Anderson–Fabry disease
por: Salamon, Irene, et al.
Publicado: (2021)

Cardiac and skeletal myopathy in Fabry disease: a clinicopathologic correlative study()()
por: Chimenti, Cristina, et al.
Publicado: (2012)

Electrocardiogram analysis in Anderson-Fabry disease: a valuable tool for progressive phenotypic expression tracking
por: Parisi, V., et al.
Publicado: (2023)

Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease?
por: Duro, Giovanni, et al.
Publicado: (2018)

Clinical Diversity in Patients with Anderson-fabry Disease with the R301Q Mutation
por: Yamamoto, Saori, et al.
Publicado: (2018)

Biomarkers and Imaging Findings of Anderson–Fabry Disease—What We Know Now
por: Beirão, Idalina, et al.
Publicado: (2017)

Does left ventricular function predict cardiac outcome in Anderson–Fabry disease?
por: Spinelli, Letizia, et al.
Publicado: (2020)

Radiofrequency ablation of ventricular tachycardia in Anderson–Fabry disease: a case series
por: Mills, Mark T, et al.
Publicado: (2021)

Anderson–Fabry Disease: A New Piece of the Lysosomal Puzzle in Parkinson Disease?
por: Zedde, Marialuisa, et al.
Publicado: (2022)

Left atrial strain correlates with severity of cardiac involvement in Anderson-Fabry disease
por: Halfmann, Moritz C., et al.
Publicado: (2022)

Sex Differences in Anderson–Fabry Cardiomyopathy: Clinical, Genetic, and Imaging Analysis in Women
por: Faro, Denise Cristiana, et al.
Publicado: (2023)

Transcatheter Tricuspid Valve Replacement for Anderson Fabry Disease With Severe Tricuspid Regurgitation
por: Zhou, Guang-Wei, et al.
Publicado: (2022)

Fever of Unknown Origin: An Unusual Case
por: Bansal, R. A., et al.
Publicado: (2011)

Fever of unknown origin (FUO) revised
por: Unger, Manuel, et al.
Publicado: (2016)

Aortitis Presenting as Fever of Unknown Origin
por: Yuan, Shi-Min, et al.
Publicado: (2018)

Thyroid Scintigraphy in Fever of Unknown Origin
por: Mohanty, Rashmi Ranjan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_feju8o5v0i6rf425scguc9612s